Efficacy and safety of zanubrutinib monotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma: A multicenter, real-world study in China

被引:0
|
作者
Luo, Jing [1 ]
Zhang, Jiaojiao [1 ]
Liu, Ligen [2 ]
Wei, Rong [3 ]
Yao, Yonghua [4 ]
Xu, Min [5 ]
Shi, Jumei [6 ]
Yang, Jianmin [7 ]
Hou, Jian [8 ]
Wang, Jin [1 ]
Mi, Jian-Qing [1 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hematol, Natl Res Ctr Translat Med Shanghai,Sch Med,State K, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Hematol, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai Peoples Hosp 10, Peoples Hosp 10, Dept Hematol, Shanghai, Peoples R China
[4] Univ Shanghai Sci & Technol, Shidong Hosp, Dept Hematol, Shanghai, Peoples R China
[5] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Hematol, Shanghai, Peoples R China
[6] Tongji Univ, Shanghai East Hosp, Shanghai Peoples Hosp 10, Peoples Hosp 10, Shanghai, Peoples R China
[7] Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China
[8] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Hematol, Shanghai, Peoples R China
关键词
D O I
10.1002/ajh.27519
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:172 / 175
页数:4
相关论文
共 50 条
  • [41] Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Philip Lee
    Kristin D. Kistler
    Luc Douyon
    Raisa Volodarsky
    Alex Young
    Sudeep Karve
    Swetha Challagulla
    Drugs - Real World Outcomes, 2023, 10 : 11 - 22
  • [42] Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Jain, Nitin
    Eyre, Toby A.
    Winfree, Katherine B.
    Bhandari, Naleen Raj
    Khanal, Manoj
    Sugihara, Tomoko
    Chen, Yongmei
    Abada, Paolo
    Patel, Krish
    LEUKEMIA & LYMPHOMA, 2025,
  • [43] Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
    Jelloul, Fatima Zahra
    Chen, Qiang Hua
    Yang, Tianyu
    Brody, Judith
    Zhang, Xinmin
    Fayyaz, Silvat Sheikh
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A116 - A116
  • [44] Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Lee, Philip
    Kistler, Kristin D.
    Douyon, Luc
    Volodarsky, Raisa
    Young, Alex
    Karve, Sudeep
    Challagulla, Swetha
    DRUGS-REAL WORLD OUTCOMES, 2023, 10 (01) : 11 - 22
  • [45] BTK Inhibitors Versus Venetoclax as First- or Second-Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Evidence Study
    Roeker, Lindsey E.
    Han, Yi
    Teschemaker, Anna
    Mato, Anthony R.
    Thompson, Meghan C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (04) : 720 - 723
  • [46] Real-World Risk of Major Bleeding Events in BTKi-Treated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL)
    Moslehi, Javid J.
    Wahlstrom, Svea K.
    Teschemaker, Anna
    Mackey, Rachel H.
    Devincenzo, Diana
    Carabuena, Leslie A.
    Thompson, Samantha L.
    Gordon, Brittaney-Belle Elizabeth
    Rosenthal, Ning A.
    BLOOD, 2024, 144 : 5109 - 5110
  • [47] Real-world understanding of the unmet need for treatment of non-covalent BTKi in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL)
    Choksi, Rushir J.
    Hou, Jing-Zhou
    Li, John
    Gart, Mike
    Vasudevan, Anupama
    Blanc, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis
    Xu, Wei
    Yang, Shenmiao
    Zhou, Keshu
    Pan, Ling
    Li, Zengjun
    Gao, Sujun
    Zhou, Daobin
    Hu, Jianda
    Feng, Ru
    Huang, Haiwen
    Wang, Tingyu
    Li, Dengju
    Ji, Meng
    Guo, Haiyi
    Zhao, Xia
    Wu, Binghao
    Yu, Yiling
    Wang, Yu
    Huang, Jane
    Novotny, William
    Li, Jianyong
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 712 - 716
  • [49] Real-World Treatment Switching and Sequencing to Next Line of Therapy of Zanubrutinib, Acalabrutinib, and Ibrutinib in Chronic/Small Lymphocytic Leukemia (CLL/SLL)
    Pinilla-Ibarz, Javier
    Xue, Mei
    Wu, Elizabeth
    Esselman, Kaitlyn
    Furnback, Wesley
    Challagulla, Swetha
    Yang, Keri
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S358 - S359
  • [50] Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Case Study
    Nanni, Danielle
    JOURNAL OF DIAGNOSTIC MEDICAL SONOGRAPHY, 2024, 40 (03) : 289 - 293